Curreen Merlin, Lidmila Jed
Community Mental Health & Addiction Services, Northland District Health Board, Whangarei, New Zealand.
Opioid Substitution Treatment Service, Northland District Health Board, Kaitaia, Whangarei, New Zealand.
Int J Risk Saf Med. 2014;26(4):183-9. doi: 10.3233/JRS-140633.
To examine the research on the dependence and abuse potential of zopiclone and the concerns that may be raised for addiction treatment services and General Practice. The focus is on four main areas: Problems that may arise from recommended use; Driving; Issues relating to dependence, and Abuse or recreational misuse.
Internet-based searches were carried out using the key descriptors of zopiclone and driving, road traffic accidents, dependence, withdrawal, abuse, misuse and overdose.
Problems arising from recommended use are rare and almost always confined to common side-effects. Driving-related studies indicate the potential for driving impairment for up to 12 hours following use and this has clear implications for both addiction services and general practice. The likelihood of dependence increases once recommended doses and time-frames are exceeded and vulnerable populations such as psychiatric patients and those with addiction problems are at risk.
Somewhat contrary to impressions that Zopiclone has little or no abuse potential, there is evidence that this medication is prescribed at higher than recommended doses and for longer than recommended. It can also be obtained readily other than by prescription. The potential for deliberate abuse may now be regarded as established, albeit at low levels compared to the benzodiazepines and this requires a degree of vigilance by prescribers and care managers.
研究佐匹克隆的依赖性和滥用潜力,以及成瘾治疗服务和全科医疗可能面临的相关问题。重点关注四个主要领域:推荐使用可能引发的问题;驾驶;与依赖性相关的问题,以及滥用或娱乐性误用。
利用佐匹克隆、驾驶、道路交通事故、依赖性、戒断反应、滥用、误用和过量使用等关键描述词进行基于互联网的搜索。
推荐使用引发的问题罕见,且几乎总是局限于常见的副作用。与驾驶相关的研究表明,使用后长达12小时存在驾驶能力受损的可能性,这对成瘾服务和全科医疗都有明确影响。一旦超过推荐剂量和时限,依赖性的可能性就会增加,精神病患者和有成瘾问题的人群等弱势群体面临风险。
与佐匹克隆几乎没有或仅有极小滥用潜力的印象有些相反,有证据表明这种药物的处方剂量高于推荐剂量,用药时间也长于推荐时间。它也可以通过非处方途径轻易获得。尽管与苯二氮䓬类药物相比,故意滥用的可能性目前处于较低水平,但已被视为确实存在,这需要开处方者和护理管理人员保持一定程度的警惕。